CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
50 hedge funds and large institutions have $26.6M invested in Carisma Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 58 → 50 (-8)
33% less capital invested
Capital invested by funds: $39.6M → $26.6M (-$13M)
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Holders
50
Holding in Top 10
1
Calls
$1.59M
Puts
$479K
Top Buyers
| 1 | +$404K | |
| 2 | +$333K | |
| 3 | +$314K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$122K |
| 5 |
Barclays
London,
United Kingdom
|
+$92.8K |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$392K | |
| 3 | -$279K | |
| 4 |
Jane Street
New York
|
-$154K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$66.8K |